ArticleThrombosis journal2016

Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting.

Luigi Brunetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.